2 February 2012

Trading Update: Half-Year Result 2012 Financial Year

Adelaide, Australia, 2 February 2012 – Ellex Medical Lasers Limited (ASX:ELX), today announced that as a result of improved revenues and operating cost reductions, the Company expects profit before tax for the six months ended 31 December 2011 to be approximately 50% higher than the profit before tax for the prior comparative period.

Group revenues are expected to be approximately 15% higher during the same period in fiscal year 2011. This level of revenue has been achieved despite the continued appreciation of the AUD against the USD, JPY and EUR; the Company’s major trading currencies.

Sales volumes and average selling prices were higher than the prior comparative period.

“I am pleased that initiatives introduced at the start of this financial year seem to be gaining traction,” said Ellex CEO, Tom Spurling.

Ellex expects to release its half-year results during the week ending 24 February 2012.

ABOUT ELLEX

Ellex Medical Lasers Limited (ASX:ELX) is a global leader in the design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye disease. With more than 15,000 systems delivered to the market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan, Germany and Australia, and a network of distribution partners in more than 100 countries. In recent years, Ellex has diversified its product range beyond lasers and ultrasound equipment to include distribution of a number of complementary third-party ophthalmic products.